ARTICLE | Company News
Tm Bioscience, bioMerieux IP deal
March 3, 2003 8:00 AM UTC
Tm Bioscience (TSE:TMC) non-exclusively licensed from bioMerieux (Marcy l'Etoile, France) IP covering the Factor II (prothrombin) and Factor V Leiden gene for use in TMC's Tag-It Mutation detection ki...